• Nenhum resultado encontrado

J. bras. pneumol. vol.41 número3

N/A
N/A
Protected

Academic year: 2018

Share "J. bras. pneumol. vol.41 número3"

Copied!
1
0
0

Texto

(1)

http://dx.doi.org/10.1590/S1806-37132015000000026

Intracavitary pulmonary aspergilloma: endoscopic aspects

Aspergiloma pulmonar intracavitário: aspectos endoscópicos

Evelise Lima1, André Louis Lobo Nagy1, Rodrigo Abensur Athanazio2

1. Attending Physician. Department of Respiratory Endoscopy, Heart Institute, University of São Paulo School of Medicine Hospital das Clínicas, São Paulo, Brazil.

2. Attending Physician. Department of Pulmonology, Heart Institute, University of São Paulo School of Medicine Hospital das Clínicas, São Paulo, Brazil.

A 49-year-old female patient presented with a diagnosis of parathyroid carcinoma that had been made in 2007. She underwent surgical treatment and chemotherapy.

Five years later, the patient developed cough and fever. A CT scan of the chest revealed a thin-walled cavitary lesion in the right upper lobe. Bronchoscopy with transbronchial biopsy confirmed the diagnosis of pulmonary metastasis. After radioablation therapy, the patient developed cavitary sequelae that were followed up radiologically.

A follow-up CT scan of the chest obtained in 2013 revealed an increase in the size of the cavitary lesion, thickening of its walls, and an intracavitary image suggestive of fungus ball.

The patient underwent a second bronchoscopy, which showed structural change in the apical

segment of the right upper lobe, with a large cavity containing an extensive, whitish, exophytic, irregular mass.

Biopsies and bronchoalveolar lavage were performed that confirmed the diagnosis of infection with Aspergillus fumigatus.

The patient was started on oral antifungal treatment and began outpatient follow-up treatment.

Aspergillosis is a multifaceted disease whose clinical manifestations (allergic, saprophytic, and invasive forms) are determined by the host immune response.

Invasive pulmonary aspergillosis has emerged as an infectious disease of high morbidity and mortality in immunocompromised patients and should be treated early. Voriconazole is recommended as the treatment of choice.

In some cases, there can be extensive destruction of the parenchymal architecture, allowing communication with the central airway and enabling endoscopic intracavitary visualization. However, this is an extremely rare finding. In the literature, case reports are limited to patients with endobronchial aspergilloma. Endoscopically, whitish necrotic masses suggest fungal infection. However, the diagnosis should be confirmed via histopathological documentation and positive culture.

Recommended reading

1. Schweer KE, Bangard C, Hekmat K, Cornely OA. Chronic pulmonary aspergillosis. Mycoses. 2014;57(5):257-70. http://dx.doi.org/10.1111/myc.12152

2. Patterson KC, Strek ME. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014;146(5):1358-68. http://dx.doi.org/10.1378/ chest.14-0917

3. Ma JE, Yun EY, Kim YE, Lee GD, Cho YJ, Jeong YY, et al. Endobronchial aspergilloma: report of 10 cases and literature review. Yonsei Med J. 2011;52(5):787-92. http://dx.doi.org/10.3349/ymj.2011.52.5.787

Figure 1 - In A, CT scan of the chest showing an intracavitary mass suggestive of fungus ball. In B, right upper lobe orifice showing destruction of the architecture of the apical segment. In C and D, a whitish intracavitary mass with areas of necrosis and an endoscopic appearance suggestive of fungal infection.

A B

C D

J Bras Pneumol. 2015;41(3):285-285

Referências

Documentos relacionados

Surgery Section, Heart Institute, University of São Paulo School of Medicine Hospital das Clínicas , São.

Pulmonary Hypertension Group, Department of Pulmonology, Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo – InCor/HCFMUSP,

* Study carried out in the Department of Pulmonology, Heart Institute, University of São Paulo School of Medicine Hospital das Clínicas, São Paulo, Brazil.. Correspondence to:

Respiratory Muscle Research Group, Pulmonary Division, Instituto do Coração – Incor, Heart Institute – University of São Paulo School of Medicine Hospital das Clínicas, São

*Study carried out at the Instituto do Coração – InCor, Heart Institute – University of São Paulo School of Medicine Hospital das Clínicas, São Paulo, Brazil.. Correspondence

Interstitial Lung Disease Group, Instituto do Coração – InCor, Heart Institute – University of São Paulo School of Medicine Hospital das Clínicas, São Paulo, Brazil. Daniel

Laboratory of Experimental Air Pollution, School of Medicine, Physics Institute, Chemistry Institute, University of São Paulo, Brazil, Pulmonary Research Group, Department of

Physician in the Pulmonary Hypertension Group of the Pulmonology Department of the University of São Paulo School of Medicine, São Paulo, Brazil.. Head of the Pulmonary